GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » 3-D Matrix Ltd (OTCPK:DMTRF) » Definitions » YoY EBITDA Growth

3-D Matrix (3-D Matrix) YoY EBITDA Growth : 76.70% (As of Jan. 2024)


View and export this data going back to 2013. Start your Free Trial

What is 3-D Matrix YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. 3-D Matrix's YoY EBITDA Growth for the quarter that ended in Jan. 2024 was 76.70%.

3-D Matrix's EBITDA per Share for the three months ended in Jan. 2024 was $-0.05.


3-D Matrix YoY EBITDA Growth Historical Data

The historical data trend for 3-D Matrix's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3-D Matrix YoY EBITDA Growth Chart

3-D Matrix Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.71 -10.13 52.56 35.46 -1.37

3-D Matrix Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -57.25 -253.85 118.18 -122.22 76.70

3-D Matrix YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

3-D Matrix's YoY EBITDA Growth for the fiscal year that ended in Apr. 2023 is calculated as:

YoY EBITDA Growth (A: Apr. 2023 )
=(EBITDA per Share (A: Apr. 2023 )-EBITDA per Share (A: Apr. 2022 ))/ | EBITDA per Share (A: Apr. 2022 ) |
=(-0.297--0.293)/ | -0.293 |
=-1.37 %

3-D Matrix's YoY EBITDA Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EBITDA Growth (Q: Jan. 2024 )
=(EBITDA per Share (Q: Jan. 2024 )-EBITDA per Share (Q: Jan. 2023 )) / | EBITDA per Share (Q: Jan. 2023 )) |
=(-0.048--0.206)/ | -0.206 |
=76.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3-D Matrix YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of 3-D Matrix's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


3-D Matrix (3-D Matrix) Business Description

Traded in Other Exchanges
Address
3-2-4 Kojimachi, Chiyoda-ku, 7th floor, Kojimachi HF Building, Tokyo, JPN, 102-0083
3-D Matrix Ltd is engaged in the research, development, manufacture, and sale of medical devices based on the self-assembling peptide technology. Its products include PuraMatrix, High Concentration PuraMatrix, Modified Peptide and GMP Grade PuraMatrix.

3-D Matrix (3-D Matrix) Headlines

No Headlines